Rapid Detection of Mycobacterium tuberculosis and Rifampin Resistance by Use of On-Demand, Near-Patient Technology
Open accessThe DOI matches its Crossref record; 58 of the 59 references it cites were found in a registry or an index.
Abstract
Current nucleic acid amplification methods to detect Mycobacterium tuberculosis are complex, labor-intensive, and technically challenging. We developed and performed the first analysis of the Cepheid Gene Xpert System's MTB/RIF assay, an integrated hands-free sputum-processing and real-time PCR system with rapid on-demand, near-patient technology, to simultaneously detect M. tuberculosis and rifampin resistance. Analytic tests of M. tuberculosis DNA demonstrated a limit of detection (LOD) of 4.5 genomes per reaction. Studies using sputum spiked with known numbers of M. tuberculosis CFU predicted a clinical LOD of 131 CFU/ml. Killing studies showed that the assay's buffer decreased M. tuberculosis viability by at least 8 logs, substantially reducing biohazards. Tests of 23 different commonly occurring rifampin resistance mutations demonstrated that all 23 (100%) would be identified as rifampin resistant. An analysis of 20 nontuberculosis mycobacteria species confirmed high assay specificity. A small clinical validation study of 107 clinical sputum samples from suspected tuberculosis cases in Vietnam detected 29/29 (100%) smear-positive culture-positive cases and 33/39 (84.6%) or 38/53 (71.7%) smear-negative culture-positive cases, as determined by growth on solid medium or on both solid and liquid media, respectively. M. tuberculosis was not detected in 25/25 (100%) of the culture-negative samples. A study of 64 smear-positive culture-positive sputa from retreatment tuberculosis cases in Uganda detected 63/64 (98.4%) culture-positive cases and 9/9 (100%) cases of rifampin resistance. Rifampin resistance was excluded in 54/55 (98.2%) susceptible cases. Specificity rose to 100% after correcting for a conventional susceptibility test error. In conclusion, this highly sensitive and simple-to-use system can detect M. tuberculosis directly from sputum in less than 2 h.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Previous studies have shown that Xpert does not cross‐react with other mycobacterial species (Blakemore 2010; Helb 2010).”
From Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults (2021) · cites this paper as Helb 2010
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This represents a substantial reduction in diagnostic delay, thereby permitting real-time decision making and planning of treatment (5).”
From Xpert MTB/RIF for Rapid Diagnosis of Tuberculous Lymphadenitis from Fine-Needle-Aspiration Biopsy Specimens (2011) · cites this paper as [5]
The cited source says what the claim attributes to it.
In the citing paper
“Previous studies reported 98–100% agreement in detection of rifampicin resistance strains using the Xpert test and phenotypic drug susceptibility test [13,14,18,26].”
From GeneXpert MTB/RIF Assay for the Diagnosis of Tuberculous Lymphadenitis on Concentrated Fine Needle Aspirates in High Tuberculosis Burden Settings (2015) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“Such cases (Xpert-positive but culture-negative) are likely to be true TB positives as corroborated by the high specificity [14,18] and by the fact that the procedure is less prone to contamination due to the closed reaction chamber (real-time PCR technology) of Xpert.”
From GeneXpert MTB/RIF Assay for the Diagnosis of Tuberculous Lymphadenitis on Concentrated Fine Needle Aspirates in High Tuberculosis Burden Settings (2015) · cites this paper as [18]
The cited source says what the claim attributes to it.
In the citing paper
“In agreement with other studies [9,18,22], Xpert has a higher sensitivity than smear microscopy.”
From GeneXpert MTB/RIF Assay for the Diagnosis of Tuberculous Lymphadenitis on Concentrated Fine Needle Aspirates in High Tuberculosis Burden Settings (2015) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Griffith, D. E., Aksamit, T., Brown-Elliott, B. A., Catanzaro, A., Daley, C., Gordin, F., Holland, S. M., Horsburgh, R., Huitt, G., Iademarco, M. F., et al. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200604-571st · Cited by 6,110
Two-sided confidence intervals for the single proportion: comparison of seven methods
Newcombe, R. G. (1998) · Statistics in Medicine · doi:10.1002/(sici)1097-0258(19980430)17:8<857::aid-sim777>3.0.co;2-e · Cited by 5,107
Probable Inference, the Law of Succession, and Statistical Inference
Wilson, E. B. (1927) · Journal of the American Statistical Association · doi:10.1080/01621459.1927.10502953 · Cited by 4,476
Sexually transmitted diseases treatment guidelines
Burstein, G. R., & Workowski, K. A. (2003) · Current Opinion in Pediatrics · doi:10.1097/00008480-200308000-00006 · Cited by 2,072
Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines
Workowski, K. A., & Berman, S. M. (2007) · Clinical Infectious Diseases · doi:10.1086/511430 · Cited by 1,973
The association for the advancement of medical instrumentation
(1974) · Ultrasound in Medicine & Biology · doi:10.1016/0301-5629(74)90035-0 · Cited by 1,031
Anti-tuberculosis drug resistance in the world
Wilkinson, D. (1998) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(98)90766-0 · Cited by 700
Molecular Detection of Antimicrobial Resistance
Fluit, A. C., Visser, M. R., & Schmitz, F.-J. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.4.836-871.2001 · Cited by 525 · cited 1×
“tuberculosis detection (15), this assay was too complex and too prone to operator errors, sample cross-contamination, and biohazards for rapid near-patient use.”
BackgroundEspinal, M. A., Kim, S. J., Suarez, P. G., Kam, K. M., Khomenko, A. G., Migliori, G. B., Baéz, J., Kochi, A., Dye, C., & Raviglione, M. C. (2000) · JAMA · doi:10.1001/jama.283.19.2537 · Cited by 507 · cited 3×
“Truly rapid results for drug susceptibility tests are particularly important in the management of drug-resistant tuberculosis (13).”
BackgroundMicroscopic-Observation Drug-Susceptibility Assay for the Diagnosis of TB
Moore, D. A. J., Evans, C. A. W., Gilman, R. H., Caviedes, L., Coronel, J., Vivar, A., Sanchez, E., Piñedo, Y., Saravia, J. C., Salazar, C., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa055524 · Cited by 468
Cited by
Items 301–400 of 940
Reither, K., Manyama, C., Clowes, P., Rachow, A., Mapamba, D. A., Steiner, A., Ross, A. J., Mfinanga, E. H., Sasamalo, M., Nsubuga, M. M., et al. (2014) · Journal of Infection · doi:10.1016/j.jinf.2014.10.003 · Cited by 31
“This notion is supported by data showing that Xpert MTB/ RIF does not detect TB in spiked sputum samples with less than 131 colony forming units per mL.(26) On the other hand, uncertainties regarding group specific clinical reference standards must be taken into consideration.”
ResultBeal, S. G., Assarzadegan, N., & Rand, K. H. (2015) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2016.1134325 · Cited by 31
“[43,47,48] The Xpert MTB/RIF can be used under varying temperature and humidity conditions and requires”
MethodExtensively Drug-Resistant Tuberculosis
Wilson, J. W., & Tsukayama, D. T. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2016.01.014 · Cited by 29
“n XXX 20 resistance to rifampin.(39) The identification of rifampin resistance is often considered a surrogate marker for the presence of MDR-TB.”
BackgroundMasenga, S. K., Mubila, H., & Hamooya, B. M. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2750-9 · Cited by 29
“We employed standard Laboratory protocols based on published guidelines [11] .”
MethodRamos, L., Obregón‐Henao, A., Henao-Tamayo, M. I., Bowen, R. A., Lunney, J. K., & Juarrero, M. G. (2017) · Tuberculosis · doi:10.1016/j.tube.2017.07.003 · Cited by 30
Simple stool processing method for the diagnosis of pulmonary tuberculosis using GeneXpert MTB/RIF
Andriyoko, B., Janiar, H., Kusumadewi, R., Klinkenberg, E., de Haas, P., & Tiemersma, E. W. (2018) · European Respiratory Journal · doi:10.1183/13993003.01832-2018 · Cited by 28
Agizew, T., Boyd, R., Auld, A. F., Payton, L., Pals, S. L., Lekone, P. E., Chihota, V. N., & Finlay, A. (2019) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.18.0203 · Cited by 28
Li, Z. (2022) · Journal of Analytical Methods in Chemistry · doi:10.1155/2022/2915018 · Cited by 28
“[35] published the first report on MTB/RIF of the Xpert system in 2010.”
Kim, C.-H., Woo, H., Hyun, I. G., Kim, C., Choi, J.-H., Jang, S.-H., Park, S. M., Kim, D.-G., Lee, M. G., Jung, K.-S., et al. (2014) · PubMed · doi:10.3978/j.issn.2072-1439.2014.04.12 · Cited by 28
Microsystem Technologies for Medical Applications
Cima, M. J. (2011) · Annual Review of Chemical and Biomolecular Engineering · doi:10.1146/annurev-chembioeng-061010-114120 · Cited by 34
“A recent study deployed benchtop automated polymerase chain reaction (PCR) machines in a multicenter trial in developing countries (15, 16).”
MethodTaylor, N., Gaur, R. L., Baron, E. J., & Banaei, N. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.01012-12 · Cited by 28
Suzana, S., Ninan, M. M., Gowri, M. S., Krishnan, V., Rupali, P., & Michael, J. S. (2015) · Tropical Medicine & International Health · doi:10.1111/tmi.12655 · Cited by 35
“Studies using sputum spiked with known numbers of M. tuberculosis colony-forming units (CFU) demonstrate a clinical limit of detection of 131 CFU/ml [5].”
BackgroundReed, J. L., Basu, D., Butzler, M. A., & McFall, S. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-03930-3 · Cited by 31
Sabur, N. F., Esmail, A., Brar, M. S., & Dheda, K. U. J. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2914-7 · Cited by 31
“tuberculosis and rifampicin resistance, [3] as the initial”
BackgroundProgress on Diagnosis of Tuberculous Meningitis
Wang, Y., & Xie, B.-D. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7717-8_20 · Cited by 29
Устинова, В. В., Смирнова, Т. Г., Гарриевич, С. Д., Varlamov, D. A., Ларионова, Е. Е., Andreevskaya, S. N., Andrievskaya, I. Y., Киселева, Е. А., Черноусова, Л. Н., & Эргешов, А. Э. (2018) · Tuberculosis · doi:10.1016/j.tube.2018.10.004 · Cited by 28
Goosen, W. J., Kerr, T. J., Kleynhans, L., Warren, R. M., van Helden, P. D., Persing, D. H., Parsons, S. D. C., Buss, P. E., & Miller, M. A. (2020) · Scientific Reports · doi:10.1038/s41598-020-71568-9 · Cited by 29
Self-citationThe diagnostic utility of line probe assays for multidrug-resistant tuberculosis
Ninan, M. M., Gowri, M. S., Christopher, D. J., Rupali, P., & Michael, J. S. (2016) · Pathogens and Global Health · doi:10.1080/20477724.2016.1214350 · Cited by 27
Efetividade do GeneXpert® no diagnóstico da tuberculose em pessoas que vivem com HIV/aids
de Faria, M. G. B. F., Andrade, R. L. D. P., Camillo, A. J. G., Leite, K. F. D. S., Saita, N. M., Bóllela, V. R., de Rezende, C. E. M., & Monroe, A. A. (2021) · Revista de Saúde Pública · doi:10.11606/s1518-8787.2021055003125 · Cited by 32
New insight in molecular detection of Mycobacterium tuberculosis
Mousavi-Sagharchi, S. M. A., Afrazeh, E., Seyyedian-Nikjeh, S. F., Meskini, M., Doroud, D., & Siadat, S. D. (2024) · AMB Express · doi:10.1186/s13568-024-01730-3 · Cited by 33
“The GeneXpert system has revolutionized TB diagnostics in resource-limited settings, where its user-friendliness and minimal infrastructure requirements have made it an invaluable tool for TB con-trol programs (Helb et al. 2010).”
MethodUse of string test and stool specimens to diagnose pulmonary tuberculosis
DiNardo, A. R., Hahn, A., Leyden, J., Stager, C. E., Baron, E. J., Graviss, E. A., Mandalakas, A. M., & Guy, E. (2015) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2015.10.022 · Cited by 27
Shrestha, P., Arjyal, A., Caws, M., Prajapati, K. G., Karkey, A., Dongol, S., Mahat, S. P., Prajapati, S., & Basnyat, B. (2015) · Tuberculosis Research and Treatment · doi:10.1155/2015/102430 · Cited by 27
Deggim, V., Somoskövi, Á., Voit, A., Böttger, E. C., & Bloemberg, G. V. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.00151-13 · Cited by 27
Novel human recombinant antibodies against Mycobacterium tuberculosis antigen 85B
Fuchs, M., Kaempfer, S., Helmsing, S., Spallek, R., Oehlmann, W., Prilop, W., Frank, R., Dübel, S., Singh, M., & Hust, M. (2014) · BMC Biotechnology · doi:10.1186/1472-6750-14-68 · Cited by 28
“nucleic acid amplification tests such as the Gene Xpert MTB/RIF [4]).”
MethodBunyasi, E. W., Tameris, M. D., Geldenhuys, H. D., Schmidt, B., Luabeya, A. K. K., Mulenga, H., Scriba, T. J., Hanekom, W. A., Mahomed, H., McShane, H., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141623 · Cited by 27
“Sample processing/preparation, PCR amplification and detection are integrated into a single self-enclosed test cartridge, and following sample loading, all steps in the assay are completely automated and self-contained [3,4].”
InfluentialTuberculosis/toxoplasmosis co-infection in Egyptian patients: A reciprocal impact
Mashaly, M. E.-S., Nabih, N., Fawzy, I., & Elhenawy, A. A. (2017) · Asian Pacific Journal of Tropical Medicine · doi:10.1016/j.apjtm.2017.03.012 · Cited by 27
Liu, Q., Lim, B. K., Lim, S. Y., Tang, W., Gu, Z., Chung, J., Park, M. K., & Barkham, T. (2017) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2017.08.181 · Cited by 27
Hai, H., Zhang, Y., Li, S., Wang, J., Chen, J., Pan, Z., & Gan, H. (2017) · Microbial Drug Resistance · doi:10.1089/mdr.2017.0114 · Cited by 27
Lu, Y., Zhu, Y., Shen, N., Tian, L., & Sun, Z. (2018) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2018.01.030 · Cited by 27
Identification of infectious organisms in cytopathology: A review of ancillary diagnostic techniques
Allison, D. B., Simner, P. J., & Ali, S. Z. (2018) · Cancer Cytopathology · doi:10.1002/cncy.22023 · Cited by 29
“Finally, some laboratories have begun performing polymerase chain reaction (PCR) on fresh tissue and fluids to detect certain mycobacterial species in settings of high clinical suspicion; however, the harsh digestion required to isolate nucleic acids from mycobacteria has limited the advancement of many molecular meth…”
Thomas, T. A. (2018) · Thoracic surgery clinics/Thorac. surg. clin. · doi:10.1016/j.thorsurg.2018.09.009 · Cited by 33
Kukhtin, A., Sebastian, T., Golova, J. B., Perov, A., Knickerbocker, C., Linger, Y., Bueno, A., Qu, P., Villanueva, M., Holmberg, R. C., et al. (2019) · Lab on a Chip · doi:10.1039/c8lc01404c · Cited by 27
Merchant, S. A., Shaikh, M. J. S., & Nadkarni, P. M. (2022) · World Journal of Radiology · doi:10.4329/wjr.v14.i6.114 · Cited by 34
Diagnostic accuracy of GeneXpert MTB/RIF assay for detection of tubercular pleural effusion
Jain, J., Jadhao, P. A., Banait, S., & Salunkhe, P. (2021) · PLoS ONE · doi:10.1371/journal.pone.0251618 · Cited by 26
Innovative laboratory methods for improved tuberculosis diagnosis and drug-susceptibility testing
Mugenyi, N., Ssewante, N., Baluku, J. B., Bongomin, F., Mutuku, I. M., Andama, A. O., & Byakika‐Kibwika, P. (2024) · Frontiers in Tuberculosis · doi:10.3389/ftubr.2023.1295979 · Cited by 28
Diagnosis of Mycobacterium tuberculosis using molecular biology technology
Garberi, J. E., Labrador, J., Garberi, F., Garberi, J. E., Peneipil, J., Garberi, M., Scigliano, L., & Troncoso, A. (2011) · Asian Pacific Journal of Tropical Biomedicine · doi:10.1016/s2221-1691(11)60002-6 · Cited by 26
“In developing countries, the technical expertise and tools needed to perform these tests are limited, and TB is often not diagnosed or treated early, which allows the disease to spread quickly in crowded living quarters and to build resistance to the drugs used in the treatment of the infection[17,18].”
BackgroundEvaluation of the Cepheid Xpert MTB/RIF assay
Shinnick, T. M., Starks, A. M., Alexander, H. L., & Castro, K. G. (2014) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.2015.976556 · Cited by 26
“A breakthrough in molecular testing for TB came with the development of Xpert MTB/RIF, an automated PCR test, run on the GeneXpert platform (Cepheid, Sunnyvale, CA, USA) [20].”
Barletta, F., Vandelannoote, K., Collantes, J., Evans, C. A., Arévalo, J., & Rigouts, L. (2014) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.13-0603 · Cited by 30
“the Gene Xpert System’s MTB/RIF assay, which detects 131 colony-forming units (CFU)/mL.(35) The most sensitive”
BackgroundEvaluation of GeneXpert MTB/RIF assay for direct diagnosis of pulmonary tuberculosis
Moussa, H. S., Bayoumi, F. S., & Ali, A. M. (2016) · Saudi Medical Journal · doi:10.15537/smj.2016.10.14998 · Cited by 26
Mvelase, N. R., Balakrishna, Y., Lutchminarain, K., & Mlisana, K. P. (2019) · BMJ Open · doi:10.1136/bmjopen-2019-031663 · Cited by 26
Bera, C., Michael, J. S., Burad, D., Shirly, S. B., Gibikote, S., Ramakrishna, B., Goel, A., & Eapen, C. E. (2015) · Indian Journal of Gastroenterology · doi:10.1007/s12664-015-0599-7 · Cited by 25
Tuberculosis Diagnosis and Management: Recent Advances
Shrivas, A., & Singh, S. (2025) · Journal of Global Infectious Diseases · doi:10.4103/jgid.jgid_112_24 · Cited by 28
“[30] The technology was considered to be a game changer.”
Li, Y., Pang, Y., Zhang, T., Xian, X., Wang, X., Yang, J., Wang, R., Chen, M., & Chen, W. (2017) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000522 · Cited by 25
Jain, P., Garing, S. H., Verma, D., Saranathan, R., Clute-Reinig, N., Gadwa, J., Peterson, C. M., Hermansky, G., Fernandez, A. A., Asare, E., et al. (2020) · Journal of Bacteriology · doi:10.1128/jb.00411-20 · Cited by 26
“While data considering diverse antibiotics and multiple resistance loci in M. tuberculosis are accumulating from next-generation sequencing efforts (7), genotypic DST is most effective for drugs with well-defined resistance mutations, as in the GeneXpert M. tuberculosis /RIF Ultra test (8).”
Application of Metagenomic Next-Generation Sequencing in Mycobacterium tuberculosis Infection
Li, Y., Jiao, M., Liu, Y., Ren, Z., & Li, A. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.802719 · Cited by 25
“Xpert, an integrated hands-free real-time PCR testing to amplify the RR-determining region (RRDR) of the MTB rpoB gene, provided us with a new perspective of detecting certain sites (25).”
MethodPeng, L., Fang, T., Cai, Q., Li, H., Li, H. Z., Sun, H., Zhu, M., Dai, L., Shao, Y., & Cai, L. (2023) · Journal of Clinical Microbiology · doi:10.1128/jcm.00923-23 · Cited by 27
Meawed, T. E., & Shaker, A. (2016) · Egyptian Journal of Chest Diseases and Tuberculosis · doi:10.1016/j.ejcdt.2016.04.005 · Cited by 25
Shao, L., Qiu, C., Zheng, L., Yang, Y., Yang, X., Liang, Q., Zhang, Y., Che, N., Pang, Y., & Duan, H. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.06.076 · Cited by 26
Trilling, A. K., de Ronde, H., Noteboom, L., van Houwelingen, A. M. M. L., Roelse, M., Srivastava, S. K., Haasnoot, W., Jongsma, M. A., Kolk, A. H. J., Zuilhof, H. T., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026754 · Cited by 25
Epidemiology of Cryptococcus gattii, British Columbia, Canada, 1999–2007
Galanis, E. (2010) · Emerging infectious diseases · doi:10.3201/eid1601.090900 · Cited by 34
Performance evaluation of the Xpert MTB/RIF assay according to its clinical application
Huh, H. J., Jeong, B., Jeon, K., Koh, W., Ki, C., & Lee, N. Y. (2014) · BMC Infectious Diseases · doi:10.1186/s12879-014-0589-x · Cited by 28
“Background The Xpert MTB/RIF assay (Xpert assay; Cepheid, Sunnyvale, CA) is a fully automated, cartridge-based, real-time polymerase chain reaction (PCR) assay designed to detect the presence of Mycobacterium tuberculosis (MTB) and rifampin (RIF) resistance within 2 hours [1,2].”
MethodAkkerman, O. W., van der Werf, T. S., de Boer, M., de Beer, J. L., Rahim, Z., Rossen, J. W. A., van Soolingen, D., Kerstjens, H. A. M., & van der Zanden, A. G. M. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.00843-13 · Cited by 25
“In the Netherlands, over a 5-year period, the IS6110 element was absent in only 3 isolates of a total of 3,884 isolates.”
BackgroundInfluentialMulti-Fluorescence Real-Time PCR Assay for Detection of RIF and INH Resistance of M. tuberculosis
Peng, J., Yu, X., Cui, Z., Xue, W., Luo, Z., Wen, Z., Liu, M., Jiang, D., Zheng, H., Wu, H., et al. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.00618 · Cited by 24
Sharma, K., Sharma, M., Chaudhary, L., Modi, M., Goyal, M., Sharma, N., Sharma, A., Jain, A., Dhibar, D. P., Jain, K., et al. (2018) · Tuberculosis · doi:10.1016/j.tube.2018.09.002 · Cited by 24
Bahizi, G., Majwala, R. K., Kisaka, S. M. B., Nyombi, A., Musisi, K., Kwesiga, B., Bulage, L., Ario, A. R., & Turyahabwe, S. (2021) · Antimicrobial Resistance and Infection Control · doi:10.1186/s13756-021-00947-2 · Cited by 24
“This test has a shorter turn-around time (about 2 h) than the gold standard method of culture (2–6 weeks) [9, 10].”
MethodIslam, M. A., Kundu, S., Hanis, T. M., Hajissa, K., & Musa, K. I. (2022) · Antibiotics · doi:10.3390/antibiotics11081012 · Cited by 28
Mukhida, S. S., Vyawahare, C., Mirza, S. B., Gandham, N. R., Khan, S., Kannuri, S., & Bhaumi, S. (2022) · Tzu Chi Medical Journal · doi:10.4103/tcmj.tcmj_86_22 · Cited by 28
“Many previous studies reported 98%–100% agreement in the detection of rifampicin resistance strains using the Xpert test and phenotypic drug susceptibility test [24-27].”
MethodSlail, M. J., Booq, R. Y., Al-Ahmad, I. H., Alharbi, A. A., Alharbi, S. F., Alotaibi, M. S. H., Aljubran, A. M., Aldossary, A. M., Memish, Z. A., Alyamani, E. J., et al. (2023) · Journal of Epidemiology and Global Health · doi:10.1007/s44197-023-00150-z · Cited by 24
“The Xpert MTB/RIF (Xpert; Cepheid, Sunnyvale, CA, USA) molecular assay was performed as described previously [28].”
MethodMwaba, P., McNerney, R., Grobusch, M. P., O’Grady, J., Bates, M., Kapata, N., Maeurer, M. J., & Zumla, A. I. (2011) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2011.02777.x · Cited by 24
“The development of a commercially available tool, the Xpert MTB ⁄ RIF assay (Cepheid, California, USA), (Helb et al. 2010; Watts, 2010; Boehme et al. 2010) has been deemed a significant development for TB diagnostics by the WHO (MTB ⁄ RIF assay recommendations: http:// www.”
MethodA feasibility study of the Xpert MTB/RIF test at the peripheral level laboratory in China
Ou, X., Xia, H., Li, Q., Pang, Y., Wang, S., Zhao, B. T., Song, Y., Zhou, Y., Zheng, Y., Zhang, Z., et al. (2014) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2014.09.011 · Cited by 24
Gazi, M. A., Islam, M. R., Kibria, M. G., & Mahmud, Z. (2015) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-014-2306-5 · Cited by 28
“7 % for smear-negative and solid-plus-liquid-culture-positive specimens [97].”
BackgroundTB Diagnostic Capacity in Sub-Saharan African HIV Care Settings
Saito, S., Howard, A. A., Reid, M. J. A., Elul, B., Scardigli, A., Verkuijl, S. E., Nyaruhirira, A. U., & Nash, D. (2012) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3182638ec7 · Cited by 24
Ba-Diallo, A., Abdoulkader, I. K., Camara, M., Lô, S., Ossoga, G. W., Mbow, M., Karam, F., Niang, M. Y. F., Thiam, A., Diawara, N. A., et al. (2016) · Pan African Medical Journal · doi:10.11604/pamj.2016.25.129.10065 · Cited by 24
“Le GX est un système basé sur la réaction de polymérisation en chaîne (PCR) en temps réel qui détecte l'ADN de MTBC et les mutations qui confèrent la résistance à la RIF en moins de 120 minutes à partir d'échantillons cliniques [9].”
Sekyere, J. O., Reta, M. A., Maningi, N. E., & Fourie, P. B. (2019) · Journal of Infection · doi:10.1016/j.jinf.2019.10.006 · Cited by 24
An Update on Global Tuberculosis (TB)
Talip, B. A., Sleator, R. D., Lowery, C. J., Dooley, J. S. G., & Snelling, W. J. (2013) · Infectious Diseases Research and Treatment · doi:10.4137/idrt.s11263 · Cited by 24
Tadesse, M., Aragaw, D., Rigouts, L., & Abebe, G. (2016) · International Journal of Mycobacteriology · doi:10.1016/j.ijmyco.2016.03.005 · Cited by 24
“Subsequently, the procedure described for direct Xpert was followed [8].”
MethodInfluentialSimieneh, A., Tadesse, M., Kebede, W., Gashaw, M., & Abebe, G. (2022) · PLoS ONE · doi:10.1371/journal.pone.0263172 · Cited by 28
Detecting Drug-Resistant Tuberculosis: The Importance of Rapid Testing
Hoek, K. G. P., Rie, A. V., van Helden, P. D., Warren, R. M., & Victor, T. C. (2011) · Molecular Diagnosis & Therapy · doi:10.1007/bf03256410 · Cited by 23
“The turnaround time is less than 2 hours, and the actual hands-on time is less than 15 minutes.([48]) The apparatus also allows for individual runs, thereby avoiding the need to batch samples.”
BackgroundUtility of the Xpert MTB/RIF Assay for Diagnosis of Tuberculous Meningitis
Boulware, D. R. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001537 · Cited by 23
Nouvelles méthodes de diagnostic de la tuberculose
Slim-Saidi, L., Mehiri, E., Ghariani, A., & Tritar, F. (2015) · Revue de Pneumologie Clinique · doi:10.1016/j.pneumo.2015.02.002 · Cited by 23
Lessells, R. J., Cooke, G., Newell, M., & Godfrey‐Faussett, P. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir412 · Cited by 33
“with rifampicin resistance [16, 17].”
Nanotools and molecular techniques to rapidly identify and fight bacterial infections
Dinarelli, S., Girasole, M., Kasas, S., & Longo, G. (2016) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2016.01.005 · Cited by 23
Agizew, T., Boyd, R., Ndwapi, N., Auld, A. F., Basotli, J., Gwebe-Nyirenda, S., Tedla, Z., Mathoma, A., Mathebula, U., Lesedi, C., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0183237 · Cited by 23
Chhajed, P. N., Vaidya, P. J., Mandovra, N. P., Chavhan, V. B., Lele, T. T., Nair, R., Leuppi, J. D., & Saha, A. (2019) · ERJ Open Research · doi:10.1183/23120541.00008-2019 · Cited by 23
Ortiz, M., Jauset‐Rubio, M., Skouridou, V., Machado, D., Viveiros, M., Clark, T. G., Šimonová, A., Kodr, D., Hocek, M., & O’Sullivan, C. K. (2021) · ACS Sensors · doi:10.1021/acssensors.1c01710 · Cited by 23
Naidoo, K., Naidoo, K., Padayatchi, N., & Karim, Q. A. (2010) · Clinical and Developmental Immunology · doi:10.1155/2011/585919 · Cited by 31
“(INH and Rif only) GeneXpert MTB/RIF 90 minutes +40% compared to ZN [22]”
ResultDomínguez, C. M., Kosaka, P. M., Sotillo, A., Mingorance, J., Tamayo, J., & Calleja, M. (2015) · Analytical Chemistry · doi:10.1021/ac504523f · Cited by 27
Engström, A. (2015) · Scandinavian Journal of Infectious Diseases · doi:10.3109/23744235.2015.1061205 · Cited by 27
Analysis of Airborne Biomarkers for Point-of-Care Diagnostics
Fung, A. O., & Mykhaylova, N. (2014) · SLAS TECHNOLOGY · doi:10.1177/2211068213517119 · Cited by 22
Sajed, A. N., Khan, S. N., Butt, A. S., Srwar, A., Akhtar, R., Ahmad, D. I., Mukhtar, M., Imran, S., Akbar, H., Ali, S., et al. (2014) · IOSR Journal of Dental and Medical Sciences · doi:10.9790/0853-131145053 · Cited by 22
Rifampicin Resistant Tuberculosis in a Secondary Health Institution in Nigeria, West Africa
Shittu, R. O. (2014) · Journal of Infectious Diseases and Therapy · doi:10.4172/2332-0877.1000139 · Cited by 22
“It can simultaneously detect Mycobacterium tuberculosis (MTB) complex DNA and mutations associated with rifampicin (RIF) resistance (a reliable proxy for) directly from sputum specimens in less than 2 hours, and it minimizes staff manipulation and bio safety risk [12].”
BackgroundHeidebrecht, C., Podewils, L. J., Pym, A. S., Cohen, T., Mthiyane, T., & Wilson, D. (2016) · Scientific Reports · doi:10.1038/srep19391 · Cited by 22
Ferguson, T. M., Weigel, K. M., Becker, A. L., Ontengco, D. D., Narita, M., Tolstorukov, I., Doebler, R. W., Cangelosi, G. A., & Niemz, A. (2016) · Scientific Reports · doi:10.1038/srep19541 · Cited by 22
Chen, J., Peng, P., Du, Y., Ren, Y., Chen, L., Rao, Y., & Wang, W. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2409-6 · Cited by 22
Value of next-generation sequencing in early diagnosis of patients with tuberculous meningitis
Lin, A., Cheng, B., Han, X., Zhang, H., Liu, X., & Liu, X. (2021) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2021.117310 · Cited by 22
Immunology of Mycobacterium tuberculosis Infections
Sia, J. K., & Rengarajan, J. (2019) · ASM Press eBooks · doi:10.1128/9781683670131.ch64 · Cited by 24
Liang, Q., Shang, Y., Huo, F., Xue, Y., Li, Y., Dong, L., Li, S., & Pang, Y. (2020) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2020.03.017 · Cited by 21
Clinical characteristics and histopathology of COVID-19 related deaths in South African adults
Nunes, M. C., Hale, M. J., Mahtab, S., Mabena, F. C., Dludlu, N., Baillie, V. L., Thwala, B. N., Els, T., du Plessis, J., Laubscher, M., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0262179 · Cited by 22
Nakiyingi, L., Nankabirwa, H., & Lamorde, M. (2013) · African Health Sciences · doi:10.4314/ahs.v13i2.46 · Cited by 21
Shenai, S., Armstrong, D. T., Valli, E., Dolinger, D. L., Nakiyingi, L., Dietze, R., Dalcolmo, M. P., Nicol, M. P., Zemanay, W., Manabe, Y., et al. (2016) · Journal of Clinical Microbiology · doi:10.1128/jcm.02847-15 · Cited by 21
“Using this normal test approach, the Xpert assay detected 250 CFU/ml in 100% of tests and detected 100 CFU/ml in 83.3% of tests, which is consistent with the previously reported Xpert LOD (10).”
BackgroundResultInfluentialSelf-citationWang, Z., Dendukuri, N., & Joseph, L. (2016) · Statistics in Medicine · doi:10.1002/sim.7148 · Cited by 21
“The culture test has a lower limit of detection than the Xpert test [10].”
BackgroundXpert MTB/RIF test for detection of pulmonary tuberculosis and rifampicin resistance
Sohn, H., Pai, M., Dendukuri, N., Kloda, L. A., Boehme, C. C., & Steingart, K. R. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009593 · Cited by 20
Self-citationBiosynthetic Enhancement of the Detection of Bacteria by the Polymerase Chain Reaction
Julie, S., Weigel, K. M., Meschke, J. S., & Cangelosi, G. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086433 · Cited by 20
Bacterial identification in the diagnostic laboratory: How much is enough?
Kootallur, B., Thangavelu, C. P., & Mani, M. (2011) · Indian Journal of Medical Microbiology · doi:10.4103/0255-0857.90156 · Cited by 20
Zhang, D., Gomez, J. E., Chien, J., Haseley, N., Desjardins, C. A., Earl, A. M., Hsueh, P., & Hung, D. T. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00664-16 · Cited by 22
“Additionally, Cepheid, whose current rapid PCR-based Xpert MTB/RIF assay (31) has been successfully implemented in clinical settings globally (32), is developing an expanded assay (Xtend XDR) to detect mutations conferring resistance to FQs, INH, amikacin, and kanamycin (33).”
MethodSample adequacy controls for infectious disease diagnosis by oral swabbing
Deviaene, M., Weigel, K. M., Wood, R. C., Luabeya, A. K. K., Jones‐Engel, L., Hatherill, M., & Cangelosi, G. A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0241542 · Cited by 21
Hu, P., Zhang, H., Fleming, J., Zhu, G., Zhang, S., Wang, Y., Liu, F., Yi, S., Chen, Z., Chen, Z., et al. (2019) · Journal of Clinical Microbiology · doi:10.1128/jcm.01707-18 · Cited by 23
“The PCR amplification program was 94°C for 3 min, followed by 30 cycles at 94°C for 1 min, 58°C for 1 min, and 72°C for 1 min, with a final extension at 72°C for 5 min.”
MethodInfluentialZhou, Y., Wei, L. C., & Chen, L. (2020) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2020.128724 · Cited by 20
Takarada, Y., Kodera, T., Kobayashi, K., Nakajima, C., Kawase, M., & Suzuki, Y. (2020) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2020.106062 · Cited by 20
Thang, L. T. H., Han, W. S., Shin, J., & Shin, J. H. (2022) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2022.132948 · Cited by 20
Metadata
- Authors
- Helb, D., Jones, M., Story, E., Boehme, C., Wallace, E., Ho, K., Kop, J., Owens, M. R., Rodgers, R., Banada, P., Safi, H., Blakemore, R., Lan, N. T. N., Jones-López, E. C., Levi, M., Burday, M., Ayakaka, I., Mugerwa, R. D., McMillan, B., Winn-Deen, E., Christel, L., Dailey, P., Perkins, M. D., Persing, D. H., & Alland, D.
- Affiliations
- Rutgers New Jersey Medical School (US)
- Cepheid (United States) (US)
- Department of Medicine, New Jersey Medical School, University of Medicine and Dentistry, New Jersey, Newark, New Jersey
- FIND (CH)
- Pham Ngoc Thach Hospital, Ho Chi Minh City, Vietnam
- Montefiore Medical Center (US)
- Makerere University (UG)
- ORCID
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 2010-01
- Volume
- 48
- Issue
- 1
- Pages
- 229-237
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- PMC
- PMC2812290
- OpenAlex
- W2112022845
- Cited by
- 914
- References
- 59
- Citations by year
- 2026: 29 · 2025: 38 · 2024: 35 · 2023: 33 · 2022: 36 · 2021: 45 · 2020: 65 · 2019: 55 · 2018: 61 · 2017: 62 · 2016: 63 · 2015: 62 · 2014: 74 · 2013: 71 · 2012: 62
- FWCI
- 41.87
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Journal of Clinical Microbiology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Rutgers University Community Repository (Rutgers University) (submittedVersion)
- Funders
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (R41AI052523, R42AI052523, R42-AI52523, R41-AI52523)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Epidemiology › Mycobacterium research and diagnosis
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Keywords
- Mycobacterium tuberculosis detection, rifampicin resistance, Xpert MTB/RIF, point-of-care testing, real-time PCR, sputum, detection limit, nontuberculous mycobacteria, retreatment tuberculosis, tuberculosis diagnosis
- MeSH terms
- Adolescent, Adult, Aged, Antitubercular Agents, Bacteriological Techniques, Female, Humans, Male, Middle Aged, Mycobacterium tuberculosis, Rifampin, Sensitivity and Specificity, Sputum, Tuberculosis, Uganda, Vietnam, Polymerase Chain Reaction, Point-of-Care Systems, Drug Resistance, Bacterial, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.